2Cotman CW. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease[J]. Neurobiol Aging, 1998, 19: 29.
3Guo Q, Christakos S, Robinson N, et al. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function[J]. Proc Natl Acad Sci USA, 1998, 95(6) :3227.
4William GJ. Late-onset neurodegenerative diseases-the role of protein insolubility[J]. J Anat, 2000, 196:609.
5Gibson RM. Does apoptosis have a role in neurodegeneration? [J]. BMJ, 2001,322(7301) : 1539.
6Yuan JY, Bruce AY. Apoptosis in the nervous system[J]. Nature, 2000, 407: 802.
7Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system[J]. Ann Rev Neurosci, 1997, 20: 245.
8Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD[J]. Nature, 1998, 391:43.
9Dubois-Dauphin M, Pfister Y, Vallet PG, et al. Prevention of apoptotic neuronal death by controlling procaspases? A point of view[J]. Brain Res Brain Res Rev, 2001,36(2-3) :196.
10Sela B. Role of caspases in neural degeneration in amyotrophic lateral sclerosis [J]. Harefuah, 2001,140 ( 11 ) :1100.
2Fornaguera J,Schwarting RK.Early behavioral changes after striatal system damage can serve as predictors of striatal dopamine depletion[J].Prog Neuropsy-chopharmacol Biol Psychiatry,1999,23(8):1353-1368.
3Reglodi D,Lubics A,Tamas A,et al.Pituitary adenylate cyclase activating poly-peptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson′s disease[J].Behav Brain Res,2004,151(1/2):303-312.
4Mcnaught KS,Olanow CW.Protein aggregation in the pathogenesis of familial and sporadic Parhnson′s disease[J].Neurobiol Aging,2006,27(4):530-545.
5Jung TW,Lee JY,Shim WS,et al.Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production[J].J Neurol Sci,2007,253(1/2):53-60.
7Ferro MM,Bellissimo MI,Anselmo-Franci JA,et al.Comparison of bilaterally 6-OHDA-and MPTP-lesioned rats as models of the early phase of Parkinson′S disease:histological,neurochemical,motor and memory alterations[J].J Neurosci Methods,2005,148(1):78-87.
8Hsieh PF,Chia LG,Ni DR,et al.Behavior,neurochemistry and histology after intranigral lipopolysaccharide injection[J].Neuroreport,2002,13(3):277-280.
9Lee JH,Zhu WM,Stanic D,et al.Sprouting of dopamine terminals and altered dopamine release and uptake in Pakinsonian dyskinaesia[J].Brain,2008,131(6):1574-1587.
10Ahmad M,Saleem S,Ahmad AS,et al.Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsionism in rats[J].Hum Exp Toxicol,2005,24(3):137-147.
